bioerodible

bioerodible

adjective Referring to polymers that exhibit controlled degradation by incorporating pro-degradant additive master batches or concentrates. Such polymers oxidise and embrittle in the environment and erode under by weathering.
References in periodicals archive ?
pSivida and Nicox have inked a partnership deal to explore the use of pSividas bioerodible sustained release drug delivery system with Nicoxs nitric oxide-donating compounds for the development of an IOP-lowering drug.
Arius brought to BDSI the BioErodible MucoAdhesive film (BEMA) technology that became the platform from which BDSI's product pipeline evolved.
In conjunction, the company is utilising its novel and proprietary BioErodible MucoAdhesive (BEMA) technology and other drug delivery technologies to develop and commercialise, either on its own or in partnership with third parties, new applications of proven therapies aimed at addressing important unmet medical needs.
An investigator-sponsored clinical trial is ongoing for an injectable, bioerodible microinsert to treat glaucoma and ocular hypertension, a product candidate on which Pfizer Inc.
The composition is bioerodible, not a denture adhesive, and substantially free of polybutene with a molecular weight of approximately 300-3000 when the composition is not an article, and is applied to dentures.
Lux will access the technology, the expertise, and the state of the art infrastructure at the Center to develop bioerodible, polymers capable of eluting drug molecules as a platform for ophthalmic drug products.
The new patents are based on inventions by Advanced Polymer Systems related to its bioerodible drug delivery systems.
The research collaboration agreement includes an option to license DSM's bioerodible polymer implant technology for evaluating its application to the delivery of certain Aerie compounds, initially focused on retinal diseases.
According to the company, BELBUCA is a mu-opioid receptor partial agonist and a potent analgesic with a long duration of action that utilises patented BioErodible MucoAdhesive (BEMA) drug delivery technology.
Independently, pSivida is developing an injectable, sustained release product to treat uveitis affecting the back of the eye (posterior uveitis) and an injectable, bioerodible product to treat glaucoma and ocular hypertension in collaboration with Pfizer.
The first patent is for the Bioerodible Mucoadhesive film drug delivery technology.